Send
Print
Oleg Dubyna
At the same time, they praised the UK government's "progressive" approach to regulating the market for e-cigarettes and other tobacco warming devices such as Philip Morris' IQOS. The company plans to focus on tobacco heating systems, anti-smoking products, etc. in the future.
Philip Morris has long been committed to reducing its share of tobacco-smoking products. In recent years, the company has invested $8.1bn in this effort.
In July alone it announced two deals that show movement in this direction, with the acquisition of Danish nicotine gum maker Fertin Pharma for $813m and UK medicinal inhaler maker Vectura for $1.4bn. Non-smoking products now account for 25% of Philip Morris' revenue and are expected to make up 50% by 2025.
source: telegraph.co.uk
Philip Morris has long been committed to reducing its share of tobacco-smoking products. In recent years, the company has invested $8.1bn in this effort.
In July alone it announced two deals that show movement in this direction, with the acquisition of Danish nicotine gum maker Fertin Pharma for $813m and UK medicinal inhaler maker Vectura for $1.4bn. Non-smoking products now account for 25% of Philip Morris' revenue and are expected to make up 50% by 2025.
source: telegraph.co.uk
